Drug intelligence / Profile preview

treated dentin matrix

Development stage
Unknown
Lead developer
Ain Shams University
Modality
Recombinant Proteins and Enzymes
Administration
Topical
01

Overview

Treated Dentin Matrix (TDM) is a bioactive, acellular scaffold derived from human dentin, developed for regenerative endodontic procedures such as pulpotomy and pulp capping. It is produced by demineralizing extracted human teeth to remove cellular components while preserving the natural extracellular matrix and endogenous bioactive proteins, including transforming growth factor-beta 1 (TGF-β1), bone morphogenetic proteins (BMPs), and fibroblast growth factors (FGFs). When applied to exposed dental pulp, TDM acts as a biological template that recruits dental pulp stem cells (DPSCs) and induces their differentiation into odontoblast-like cells, which then secrete reparative dentin. This process facilitates the formation of a dentin bridge and supports continued root development (apexogenesis) in immature permanent teeth. TDM is currently being evaluated in Phase 3 clinical trials at Ain Shams University as a biomimetic alternative to traditional materials like Mineral Trioxide Aggregate (MTA) and bioceramics for treating deep dental caries and pulp exposure.

Other names
microtubule-targeting agents-Ain Shams University-dental caries-pulp exposuredemineralized dentin matrixhuman treated dentin matrix
02

Targets

TGFBR (TGF-beta receptor)FGFR (FGFR family)BMPR (Bone morphogenetic protein receptor)

Beyond the preview

Go deeper on treated dentin matrix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on treated dentin matrix.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call